SMS PHARMACEUTICALS LTD. - 532815 - Revised - DISCLOSURE FOR INTIMATION RECEIVED FROM DESIGNATED EMPLOYEE / DISPOSAL OF EQUITY SHARES OF THE COMPANY.
Revised - We received disclosure from the designated employee in pursuant to Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 on 19th December, 2020. (by oversight it has been mentioned date as 17th December, 2020 insisted of 19th December, 2020) SMS PHARMACEUTICALS LTD. - 532815 - DISCLOSURE FOR INTIMATION RECEIVED FROM DESIGNATED EMPLOYEE / DISPOSAL OF EQUITY SHARES OF THE COMPANY
We received disclosure from the designated employee in pursuant to Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 on 17th December, 2020. Details as provide below: Sl. No. Name Category Event Number of Shares 1) Krishna Chaitanya Potluri Designated Employee sale 11,300 SMS PHARMACEUTICALS LTD. - 532815 - Regulation 7(2) Of SEBI (PIT) Regulations, 2015
This is in continuation of earlier communication dated 8th December, 2020 please find enclosed herewith the disclosure as under Regulation 7(2) of SEBI (PIT) Regulations, 2015 received from Potluri Infra Projects LLP for the pledge of 8,00,000 Equity shares of the Company. This is for your information and record SMS PHARMACEUTICALS LTD. - 532815 - DISCLOSURE FOR INTIMATION RECEIVED FROM PROMOTER GROUP FOR ACQUISITION / DISPOSAL OF EQUITY SHARES OF THE COMPANY.
We received disclosure from the following Promoter / Promoter Group in pursuant to Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011 on 9th December, 2020. SMS PHARMACEUTICALS LTD. - 532815 - REPORT REGARDING INTER-SE TRANSFER Ref: Regulation 10(6) Of SEBI (Substantial Acquisition Of Shares & Takeovers) Regulations, 2011
In furtherance to the intimation under Regulation 10(5) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 ('Takeover Regulations') submitted by Mr. Ramesh Babu Potluri, Mrs. Hima Bindu Potluri, Mr. Vamsi Krishna Potluri and M/s Potluri Infra Projects LLP ('Acquirers') on November 27, 2020, belonging to Promoter and Promoter Group of SMS Pharmaceuticals Limited ('Company'), have in aggregate acquired 87,57,500 (Eighty Seven Lakhs Fifty Seven Thousand Five Hundred) Equity Shares of the Company by way of inter-se transfer in terms of Regulation 10(1)(a)(ii) of Takeover Regulations, by way of market Purchase on December 7 & 8, 2020. SMS PHARMACEUTICALS LTD. - 532815 - Disclosure Under Regulation 31 (1) Of SEBI (SAST) Regulations, 2011 Read With SEBI Circular Number SEBI/HO/CFD/DCR1/CIR/P/2019/90 Dated August 7, 2019.
With reference to the aforementioned subject, please find enclosed herewith the disclosure received from M/s Potluri Infra Projects LLP, Promoter Group of SMS Pharmaceuticals Limited (The Company) with regard to pledge of 8,00,000 (0.95%) Equity shares of the Company, on 7th December, 2020 in favor 'Vistra ITCL India Limited. Details of encumbrance shares as on date: Sl. No Name Equity Shares held Equity shares pledged 1 Potluri Vamsi Krishna 80,10,590 20,30,590 25.35% 2 M/s Potluri Infra Projects LLP 61,04,100 38,00,000 62.26% SMS PHARMACEUTICALS LTD. - 532815 - Submission Of Half Yearly Disclosure On Related Party Transactions. Regulation 23(9) Of The SEBI (Listing Obligations And Disclosures Requirements), Regulations, 2015.
In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose disclosure of Related Party Transactions on a consolidated basis, in the format specified in the accounting standards for the half year ended 30th September, 2020. SMS PHARMACEUTICALS LTD. - 532815 - Revised Disclosure Of Inter-Se Transfer Of Shares Between Promoters/ Prompter Group In Accordance With Regulation 10(5) Of SEBI (SAST) Regualtions, 2011
In compliance with Regulation 10(5) of SEBI (SAST) Regulations, 2011, We would like to inform your good office that Acquirers, being a part of Promoter Group of SMS Pharmaceuticals Limited (herein after referred as 'the Company') intends to acquirer 87,57,500 (Eighty Seven Lakhs Fifty Seven Thousand and Five Hundred) Equity Shares of the Company by way of inter-se transfer on or after December 7, 2020, in terms of Regulation 10(1)(a)(ii) of SEBI (SAST), Regulations2011 by way of on-market. SMS PHARMACEUTICALS LTD. - 532815 - Intimation Received From Promoter / Promoter Group Regarding Inter-Se Transfer
In compliance with Regulation 10(5) of SEBI (SAST) Regulations, 2011, Company has received intimation from Promoter / Promoter Group for inter-se transfer of 87,57,500 Equity Shares of the Company on or after December 7, 2020. SMS PHARMACEUTICALS LTD. - 532815 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vamsi Krishna Potluri, Potluri Infra Projects LLP, Potluri Laboratories Pvt Ltd, TVVSN Murthy HUF, Sudeepthi Gopineedi